A versatile drug delivery system using streptavidin-tagged pegylated liposomes and biotinylated biomaterials
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Authors: Chen, Ming-Han; Soda, Yasushi; Izawa, Kiyoko; Kobayashi, Seiichiro; Tani, Kenzaburo; Maruyama, Kazuo; Tojo, Arinobu; Asano, Shigetaka
Abstract
Here we have developed a versatile liposome-mediated drug delivery system (DDS) allowing a strong bridge between the streptavidin-tagged liposome (SAL) and biotin (Bi)-tagged biomaterials which has strong affinity to surface proteins expressed in restricted cell lineages. This DDS was effective and specific for many leukemia cells in vitro and in vivo. When examining 6 human leukemia cell lines using calcein-encapsulated SALs in combination with Bi-granulocyte colony-stimulating factor (G-CSF), Bi-anti-CD33 monoclonal antibody (MAb) or Bi-anti-CD7 MAb, the fluorescent positive rate of each cell line was in almost proportion to degree of G-CSF receptor, CD33 or CD7 expression, respectively. More importantly, the binding ability was shown to be well maintained in a mouse xenograft model. Furthermore the cytosine arabinoside (AraC)-encapsulated SALs could kill the corresponding cells much more effectively in combination with Bi-biomaterials than free AraC, as expected. These findings strongly indicate that our SAL/Bi-biomaterial system could allow various types of medical agents to be delivered reliably and stably to the cells targeted. (C) 2013 Published by Elsevier B.V.
Flow Cytometric Identification of Immunophenotypically Aberrant T-Cell Clusters on Skin Shave Biopsy Specimens From Patients With Mycosis Fungoides
AMERICAN JOURNAL OF CLINICAL PATHOLOGY
Authors: Horna, Pedro; Kurant, Danielle; Sokol, Lubomir; Sotomayor, Eduardo M.; Moscinski, Lynn; Glass, L. Frank
Abstract
Objectives: To assess the ability of flow cytometry (FC) to detect putative neoplastic T-cell subsets on skin shave biopsy (SSB) specimens from patients with mycosis fungoides (MF) and to study the immunophenotype of skin-infiltrating tumor cells in ME. Methods: SSB specimens from patients with suspected ME were bisected and submitted for both FC and routine histopathology. Six-dimensional gating strategies were applied to identify putative neoplastic cells, independently from their expected immunophenotype. Results: Aberrant T cells were detected by FC in 18 of 33 SBB specimens, of which all had clinicomorphologic features of MF. Of the remaining 15 SSB specimens, six had clinicomorphologic features of ME and nine were diagnosed with benign inflammatory dermatoses. Unexpectedly, CD26 was aberrantly overexpressed in 11 (73%) and lost in three (20%) of 15 SSB specimens from patients with ME where this antigen was evaluated Other detected aberrancies included CD3 dim- (13/18[72%]), CD7 dim- (15/18[83%]), and CD4-/CD8- (3/18 [17%]). Conclusions: FC is capable of identifying putative neoplastic cells on SSB specimens from patients with MP. Bright homogeneous CD26 expression is a common and previously undescribed immunophenotypic aberrancy on ME skin infiltrates.